[Thromboprophylaxis in patients with multiply myeloma who receives chemotherapy with thalidomide].
Achievements of world practice about development and prophilaxis of tromboembolic events (VTE) in cancer patients. Particular attention is paid to prevention of VTE in patients with multiply myeloma who receive chemotherapy with Thalidomide.